يعرض 361 - 380 نتائج من 8,673 نتيجة بحث عن 'significantly ((((teer decrease) OR (mean decrease))) OR (we decrease))', وقت الاستعلام: 0.39s تنقيح النتائج
  1. 361
  2. 362
  3. 363
  4. 364
  5. 365
  6. 366
  7. 367

    Study-related adverse events. حسب Benjamin R. Lewis (22279166)

    منشور في 2025
    "…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …"
  8. 368

    Study flow chart. حسب Benjamin R. Lewis (22279166)

    منشور في 2025
    "…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …"
  9. 369

    Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

    منشور في 2025
    "…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …"
  10. 370
  11. 371
  12. 372
  13. 373
  14. 374
  15. 375

    Open data. حسب Larissa Brazolotto Ferreira (17671168)

    منشور في 2025
    الموضوعات:
  16. 376
  17. 377
  18. 378

    Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation حسب Xiaoyu Shen (4715430)

    منشور في 2025
    "…And the low-risk cohort exhibited increased immune infiltration and decreased tumor purity. Additionally, significant differences in tumor mutation profiles were observed, with the tumor mutation burden (TMB) being higher in the low-risk cohort, suggesting a potentially better response to immunotherapy. …"
  19. 379
  20. 380

    Demographics of the enrolled patients. حسب Yuka Kasai (21354922)

    منشور في 2025
    الموضوعات: